The Serum Glycome to Discriminate between Early-Stage Epithelial Ovarian Cancer and Benign Ovarian Diseases

Figure 4

Two-dimensional scatter plot classifying the cohort enrolled in this study. The horizontal line of the plot represents the cut-off limit for GLYCOV [] and the vertical line displays the limit for CA125 []. The scatter plot shows that the combination of CA125 and GLYCOV improves the diagnosis of early-stage primary EOC compared to when CA125 is used alone.